HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoko Hata Sugi Selected Research

N- (3- cyano- 4- methyl- 1H- indol- 7- yl)- 3- cyanobenzene- sulfonamide

1/2017Selective degradation of splicing factor CAPERĪ± by anticancer sulfonamides.
2/2004An angiogenesis inhibitor E7820 shows broad-spectrum tumor growth inhibition in a xenograft model: possible value of integrin alpha2 on platelets as a biological marker.
11/2002Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoko Hata Sugi Research Topics

Disease

5Neoplasms (Cancer)
01/2017 - 11/2002
1Lung Neoplasms (Lung Cancer)
10/2013
1Colorectal Neoplasms (Colorectal Cancer)
11/2002

Drug/Important Bio-Agent (IBA)

3N- (3- cyano- 4- methyl- 1H- indol- 7- yl)- 3- cyanobenzene- sulfonamideIBA
01/2017 - 11/2002
1N- (3- chloro- 7- indolyl)- 1,4- benzenedisulphonamide (E7070)IBA
01/2017
1Pharmaceutical PreparationsIBA
01/2017
15-chloroquinoxaline-2-sulfanilamide (chloroquinoxaline sulfonamide)IBA
01/2017
1Estrogen ReceptorsIBA
01/2017
1SulfonamidesIBA
01/2017
1RNA Splicing FactorsIBA
01/2017
1lenvatinibIBA
10/2013
1Tyrosine Kinase InhibitorsIBA
10/2013
1matrigelIBA
02/2004
1Biomarkers (Surrogate Marker)IBA
02/2004
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2004
1Angiogenesis InhibitorsIBA
02/2004
1Integrin alpha2IBA
02/2004

Therapy/Procedure

2Therapeutics
01/2017 - 11/2016
2Oral Administration
02/2004 - 11/2002